Pharmaceutical firms focus on development of generics for treatment of diabetes

With many global makers’ blockbuster products coming off patent, the race for the generic drug market is set to be in full force in the years to come.

The combination drug recently at the center of attention is best-selling Amaryl-M tablets, which has been marketed by Handok Pharma.

The Korea Food and Drug Administration says it received a total of 57 applications for bioequivalence testi...